HEALTHCARE
Eli Lilly’s weight loss pill succeeds in first late-stage trial on diabetes patients; shares jump 14%
Eli Lilly on Thursday said its daily obesity pill met the company's goals in the first of several late-stage trials, helping patients with...
HEALTHCARE
Eli Lilly shares surge on new obesity pill data. What it means for the stock from here
Eli Lilly is tightening its grip on the lucrative weight-loss market as it moves into a new, more convenient phase that promises to...
HEALTHCARE
Pfizer scraps daily weight loss pill after liver injury in one patient
Nikos Pekiaridis | Lightrocket | Getty ImagesPfizer on Monday said it would end development of its experimental daily weight loss pill after a...
HEALTHCARE
Pharmaceutical stocks rise as Trump pauses tariffs but not for China
The Lilly Biotechnology Center in San Diego, California, on March 1, 2023.Mike Blake | ReutersShares of some drugmakers rose on Wednesday after President...
HEALTHCARE
Trump drops Biden’s proposal for Medicare to cover obesity drugs like Wegovy and Zepbound
A combination image shows an injection pen of Zepbound, Eli Lilly's weight loss drug, and boxes of Wegovy, made by Novo Nordisk. ReutersPresident Donald...
HEALTHCARE
Healthy Returns: AstraZeneca cholesterol pill shows promise as race with Merck heats up
Signage at the AstraZeneca facility in Gaithersburg, Maryland, US, on Monday, Aug. 26, 2024. Graeme Sloan | Bloomberg | Getty ImagesA version of this...
HEALTHCARE
Novo Nordisk’s diabetes pill slashes risk of cardiovascular complications by 14% after four years
Novo Nordisk on Saturday said its diabetes pill Rybelsus showed cardiovascular benefits in a late-stage trial, paving the way for it to become...
Subscribe
– Stay updated in real-time
– Get in-depth insights and trends
– News straight to your inbox
Must read